Bacterial pneumonia in persons infected with the human immunodeficiency virus

New England Journal of Medicine

Volumn 333, Issue 13, 1995, Pages 845-851

  Hirschtick, Robert E ^a   Glassroth, Jeffrey ^a   Jordan, Matthew C ^b   Wilcosky, Timothy C ^b   Wallace, Jeanne M ^c   Kvale, Paul A ^d   Markowitz, Norman ^d   Rosen, Mark J ^e   Mangura, Bonita T ^f   Hopewell, Philip C ^g  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

^f UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMAN; MALE; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SUBSTANCE ABUSE, INTRAVENOUS; SUPPORT, U.S. GOV'T, P.H.S.; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0029074827     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199509283331305     Document Type: Article

References (41)

1. Murray JF, Felton CP, Garay SM, Pulmonary complications of the acquired immunodeficiency syndrome: report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med 1984; 310: 1682-1688
2. Murray JF, Mills J Pulmonary infectious complications of human immunodeficiency virus infection. Am Rev Respir Dis 1990; 141: 1356-1372
3. McKenzie R, Travis WD, Dolan SA, The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 1991; 70: 326-343
4. Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ Jr Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984; 130: 1174-1176
5. Polsky B, Gold JWM, Whimbey E, Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 38-41
6. Witt DJ, Craven DE, McCabe WR Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987; 82: 900-906
7. Cohn DL Bacterial pneumonia in the HIV-infected patient. Infect Dis Clin North Am 1991; 5: 485-507
8. Caiaffa WT, Graham NMH, Vlahov D Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol 1993; 138: 909-922
9. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome MMWR Morb Mortal Wkly Rep 1987; 36: Suppl 1S: 3S-9S
10. Pulmonary Complications of HIV Infection Study Group. Design of a prospective study of the pulmonary complications of human immunodeficiency virus infection. J Clin Epidemiol 1993; 46: 497-507
11. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980:119-42.
12. Selwyn PA, Feingold AR, Hartel D, Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988; 2: 267-272
13. Selwyn PA, Alcabes P, Hartel D, Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1697-1703
14. Magnenat J, Nicod LP, Auckenthaler R, Junod AF Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. Am Rev Respir Dis 1991; 144: 917-922
15. Mientjes GH, van Ameijden EJ, van den Hoek AJ, Coutinho RA Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. AIDS 1992; 6: 207-212 [Erratum, IDS 1992;6:526.]
16. Wallace JM, Rao AV, Glassroth J, Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1523-1529
17. Phair J, Munoz A, Detels R, The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990; 332: 161-165
18. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992; 5: 1069-1074
19. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992; 165: 1082-1085
20. Caiaffa WT, Vlahov D, Graham NM, Solomon L, Nelson KE, Munoz A. Risk factors for bacterial pneumonia among HIV seropositive (HIV+) intravenous drug users (IDUs). In: Abstracts of the Ninth International Conference on AIDS/Fourth STD World Congress, Berlin, Germany, June 6–11, 1993. London: Wellcome Foundation, 1993:705. abstract.
21. Janoff EN, Breiman RF, Daley CL, Hopewell PC Pneumococcal disease during HIV infection: epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992; 117: 314-324
22. Walsh TJ, Pizzo PA Treatment of respiratory infections in immunocompromised patients, pp 424-8. In: Shelhamer JH, moderator. Respiratory disease in the immunosuppressed patient. Ann Intern Med 1992; 117: 415-431
23. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M B-cell deficiency in acquired immune deficiency syndrome. JAMA 1984; 251: 1447-1449
24. Walsh TJ, Rubin M, Pizzo PA. Respiratory diseases in patients with malignant neoplasms. In: Shelhamer JH, Pizzo PA, Parrillo JE, Masur H, eds. Respiratory disease in the immunosuppressed host. Philadelphia: J.B. Lippincott, 1991:640-63.
25. Toews GB Predisposition to respiratory disease: immunologic and nonimmunologic factors, pp 415-8. In: Shelhamer JH, moderator. Respiratory disease in the immunosuppressed patient. Ann Intern Med 1992; 117: 415-431
26. Rankin JA, Collman R, Daniele RP Acquired immune deficiency syndrome and the lung. Chest 1988; 94: 155-164
27. Louria DB, Hensle T, Rose J The major medical complications of heroin addiction. Ann Intern Med 1967; 67: 1-22
28. O'Donnell AE, Pappas LS Pulmonary complications of intravenous drug abuse: experience at an inner-city hospital. Chest 1988; 94: 251-253
29. Garcia-Leoni ME, Moreno S, Rodeno P, Cercenado E, Vicente T, Bouza E Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med 1992; 152: 1808-1812
30. Fang GD, Fine M, Orloff J, New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69: 307-316
31. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671-674
32. Levy M, Dromer F, Brion N, Leturdu F, Carbon C Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988; 93: 43-48
33. Bates JH, Campbell GD, Barron AL, Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101: 1005-1012
34. Nieman RB, Fleming J, Coker RJ, Harris JRW, Mitchell DM. Cigarette smoking by HIV infected individuals is associated with a more rapid progression to AIDS. In: Abstracts of the Eighth International Conference on AIDS/Third STD World Congress, Amsterdam, July 19–24, 1992. Amsterdam: CONGREX, 1992:C312. abstract.
35. Buskin SE, Hopkins SG, Farizo KM. Heavy smoking increases the risk of Pneumocystis carinii pneumonia (PCP). In: Abstracts of the Eighth International Conference on AIDS/Third STD World Congress, Amsterdam, July 19–24, 1992. Amsterdam: CONGREX, 1992:We50. abstract.
36. Nieman RB, Coker RJ, Mitchell DM Cigarette smoking, leukocyte profiles, and HIV-1 progression. J Acquir Immune Defic Syndr 1993; 6: 1174-1176
37. Hardy WD, Feinberg J, Finkelstein DM, A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1842-1848
38. Information bias. In: Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning, 1982:220-41.
39. Schneider MME, Hoepelman AIM, Eeftinck Schattenkerk JKM, A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1836-1841
40. Masur H Prevention and treatment of pneumocystis pneumonia. N Engl J Med 1992; 327: 1853-1860
41. Carr A, Tindall B, Brew BJ, Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106-111